Vaxart VXRT
OTC VXRT
$0.36 -0.02 (-5.26%)
At close: Nov 10, 2026 · 4:00 PM EST

Vaxart (VXRT) Depreciation & Amortization (CF) (2009 - 2026)

Updated

Vaxart's Depreciation & Amortization (CF) was $741,000 in Q2 2026, down 66.3% from $2.2 million a year earlier and down 34.2% from the prior quarter.

Analysis

Vaxart (VXRT) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Vaxart's Depreciation & Amortization (CF) was $6 million through Jun 30, 2026, down 32.6% year-over-year; for FY2025, it was $8.58 million, down 3.1% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 25.9% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $8.85 million in FY2024 (+2.6%), $8.62 million in FY2023 (+48.6%), $5.81 million in FY2022 (+38.0%) and $4.21 million in FY2021 (+55.3%).
  • The Q2 2026 figure marks the lowest quarterly Depreciation & Amortization (CF) since Q3 2020.
  • Compared with a year earlier, Depreciation & Amortization (CF) has declined for five straight quarters, with an average decline of 15.6% over the last eight quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q1 2023 (growth of 82.3%); the worst was Q2 2026 (a decline of 66.3%).
  • Per Business Quant data, VXRT's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $1.13 million (Q1 2026), $2.06 million (Q4 2025) and $2.08 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 Vaxart 87.73 Mn 22.23 Mn - 1.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.27 Mn
Jun 30, 2026 741,000.00
Mar 31, 2026 1.13 Mn
Dec 31, 2025 2.06 Mn
Sep 30, 2025 2.08 Mn
Jun 30, 2025 2.20 Mn
Mar 31, 2025 2.25 Mn
Dec 31, 2024 2.24 Mn
Sep 30, 2024 2.22 Mn
Jun 30, 2024 2.21 Mn
Mar 31, 2024 2.18 Mn
Dec 31, 2023 2.33 Mn
Sep 30, 2023 2.07 Mn
Jun 30, 2023 2.17 Mn
Mar 31, 2023 2.06 Mn
Dec 31, 2022 1.89 Mn
Sep 30, 2022 1.56 Mn
Jun 30, 2022 1.22 Mn
Mar 31, 2022 1.13 Mn
Dec 31, 2021 1.20 Mn
API Access

Vaxart Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=VXRT&period=max&api_key=YOUR_API_KEY